Domain analyses of the Runx1 transcription factor responsible for modulating T-cell receptor-β\CD4 and interleukin-4\interferon-γ expression in CD4+ peripheral T lymphocytes

Immunology

Volumn 128, Issue 1, 2009, Pages 16-24

  Uchino, Ryuji ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

CD4; Runx1; T cell activation; TCR signal; Th1 2 differentiation

Indexed keywords

CD4 ANTIGEN; CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSCRIPTION FACTOR RUNX1;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; THYMOCYTE;

ANIMALS; ANTIGENS, CD; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 2 SUBUNIT; GENE DELETION; INTERFERON-GAMMA; INTERLEUKIN-4; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; TRANSDUCTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA;

EID: 68249129025     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2009.03042.x     Document Type: Article

References (38)

1. Egawa T, Tillman RE, Naoe Y, Taniuchi I, Littman DR. The role of the Runx transcription factors in thymocyte differentiation and in homeostasis of naive T cells. J Exp Med 2007 204 : 1945 57.
2. Okuda T, Takeda K, Fujita Y et al. Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy. Mol Cell Biol 2000 20 : 319 28.
3. Kagoshima H, Shigesada K, Satake M, Ito Y, Miyoshi H, Ohki M, Pepling M, Gergen P. The Runt domain identifies a new family of heteromeric transcriptional regulators. Trends Genet 1993 9 : 338 41.
4. Meyers S, Downing JR, Hiebert SW. Identification of AML-1 and the (8;21) translocation protein (AML-1\ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions. Mol Cell Biol 1993 13 : 6336 45.
5. Kitabayashi I, Yokoyama A, Shimizu K, Ohki M. Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation. EMBO J 1998 17 : 2994 3004.
6. Petrovick MS, Hiebert SW, Friedman AD, Hetherington CJ, Tenen DG, Zhang DE. Multiple functional domains of AML1: PU.1 and C\EBPalpha synergize with different regions of AML1. Mol Cell Biol 1998 18 : 3915 25.
7. Ito Y. Molecular basis of tissue-specific gene expression mediated by the runt domain transcription factor PEBP2\CBF. Genes Cells 1999 4 : 685 96.
8. Kanno T, Kanno Y, Chen LF, Ogawa E, Kim WY, Ito Y. Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2\core binding factor alpha subunit revealed in the presence of the beta subunit. Mol Cell Biol 1998 18 : 2444 54.
9. Aronson BD, Fisher AL, Blechman K, Caudy M, Gergen JP. Groucho-dependent and -independent repression activities of Runt domain proteins. Mol Cell Biol 1997 17 : 5581 7.
10. Levanon D, Goldstein RE, Bernstein Y, Tang H, Goldenberg D, Stifani S, Paroush Z, Groner Y. Transcriptional repression by AML1 and LEF-1 is mediated by the TLE\Groucho corepressors. Proc Natl Acad Sci USA 1998 95 : 11590 5.
11. Zeng C, van Wijnen AJ, Stein JL et al. Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML\CBF-alpha transcription factors. Proc Natl Acad Sci USA 1997 94 : 6746 51.
12. Sun W, Graves BJ, Speck NA. Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins. J Virol 1995 69 : 4941 9.
13. Taniuchi I, Osato M, Egawa T, Sunshine MJ, Bae SC, Komori T, Ito Y, Littman DR. Differential requirements for Runx proteins in CD4 repression and epigenetic silencing during T lymphocyte development. Cell 2002 111 : 621 33.
14. Hayashi K, Abe N, Watanabe T, Obinata M, Ito M, Sato T, Habu S, Satake M. Overexpression of AML1 transcription factor drives thymocytes into the CD8 single-positive lineage. J Immunol 2001 167 : 4957 65.
15. Hayashi K, Natsume W, Watanabe T et al. Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells. J Immunol 2000 165 : 6816 24.
16. Kohu K, Sato T, Ohno S et al. Overexpression of the Runx3 transcription factor increases the proportion of mature thymocytes of the CD8 single-positive lineage. J Immunol 2005 174 : 2627 36.
17. Woolf E, Xiao C, Fainaru O et al. Runx3 and Runx1 are required for CD8 T cell development during thymopoiesis. Proc Natl Acad Sci USA 2003 100 : 7731 6.
18. Abe N, Kohu K, Ohmori H et al. Reduction of Runx1 transcription factor activity up-regulates Fas and Bim expression and enhances the apoptotic sensitivity of double positive thymocytes. J Immunol 2005 175 : 4475 82.
19. Sato T, Ito R, Nunomura S, Ohno S, Hayashi K, Satake M, Habu S. Requirement of transcription factor AML1 in proliferation of developing thymocytes. Immunol Lett 2003 89 : 39 46.
20. + T cells into the Th2 lineage by repressing GATA3 expression. J Exp Med 2003 198 : 51 61.
21. Naoe Y, Setoguchi R, Akiyama K, Muroi S, Kuroda M, Hatam F, Littman DR, Taniuchi I. Repression of interleukin-4 in T helper type 1 cells by Runx\Cbf beta binding to the Il4 silencer. J Exp Med 2007 204 : 1749 55.
22. Ono M, Yaguchi H, Ohkura N et al. Foxp3 controls regulatory T-cell function by interacting with AML1\Runx1. Nature 2007 446 : 685 9.
23. Kawazu M, Asai T, Ichikawa M et al. Functional domains of Runx1 are differentially required for CD4 repression, TCRbeta expression, and CD4\8 double-negative to CD4\8 double-positive transition in thymocyte development. J Immunol 2005 174 : 3526 33.
24. Telfer JC, Hedblom EE, Anderson MK, Laurent MN, Rothenberg EV. Localization of the domains in Runx transcription factors required for the repression of CD4 in thymocytes. J Immunol 2004 172 : 4359 70.
25. Nishimura M, Fukushima-Nakase Y, Fujita Y, Nakao M, Toda S, Kitamura N, Abe T, Okuda T. VWRPY motif-dependent and -independent roles of AML1\Runx1 transcription factor in murine hematopoietic development. Blood 2004 103 : 562 70.
26. Misawa K, Nosaka T, Morita S, Kaneko A, Nakahata T, Asano S, Kitamura T. A method to identify cDNAs based on localization of green fluorescent protein fusion products. Proc Natl Acad Sci USA 2000 97 : 3062 6.
27. Mak TW. Insights into the ontogeny and activation of T cells. Clin Chem 1994 40 : 2128 31.
28. Palacios EH, Weiss A. Function of the Src-family kinases, Lck and Fyn, in T-cell development and activation. Oncogene 2004 23 : 7990 8000.
29. Testi R, Phillips JH, Lanier LL. T cell activation via Leu-23 (CD69). J Immunol 1989 143 : 1123 8.
30. Leitenberg D, Boutin Y, Constant S, Bottomly K. CD4 regulation of TCR signaling and T cell differentiation following stimulation with peptides of different affinities for the TCR. J Immunol 1998 161 : 1194 203.
31. Dumont C, Blanchard N, Di Bartolo V, Lezot N, Dufour E, Jauliac S, Hivroz C. TCR\CD3 down-modulation and zeta degradation are regulated by ZAP-70. J Immunol 2002 169 : 1705 12.
32. Heath VL, Murphy EE, Crain C, Tomlinson MG, O'Garra A. TGF-beta1 down-regulates Th2 development and results in decreased IL-4-induced STAT6 activation and GATA-3 expression. Eur J Immunol 2000 30 : 2639 49.
33. Hanai J, Chen LF, Kanno T et al. Interaction and functional cooperation of PEBP2\CBF with Smads. Synergistic induction of the immunoglobulin germline Calpha promoter. J Biol Chem 1999 274 : 31577 82.
34. Ito Y, Miyazono K. RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev 2003 13 : 43 7.
35. Pimanda JE, Donaldson IJ, de Bruijn MFTR et al. The SCL transcriptional network and BMP signaling pathway interact to regulate RUNX1 activity. Proc Natl Acad Sci USA 2007 104 : 840 5.
36. Leitenberg D, Bottomly K. Regulation of naive T cell differentiation by varying the potency of TCR signal transduction. Semin Immunol 1999 11 : 283 92.
37. Mowen KA, Glimcher LH. Signaling pathways in Th2 development. Immunol Rev 2004 202 : 203 22.
38. 2+ signaling. Eur J Immunol 2005 35 : 3187 95.